Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$4.71M$4.71Mderived−2.4% vs Q4 2012 Net Income-$167.35K-$167.35KderivedN/M vs Q4 2012 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$468,363N/M Operating Cash Flowderived-$21,845N/M Free Cash Flowderived-$132,248N/M Margins · derivedOperating margin10.0%+21.3 pt vs Q4 2012
Net margin-3.6%+14.2 pt vs Q4 2012
ended Nov 30, 2013 · filed Feb 28, 2014 · 90 d after period end